South Rampart Pharma Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $3.2M

  • Investors
  • 6

South Rampart Pharma General Information

Description

Developer of a clinical-stage biotech company designed to address the need for a safe and effective approach to relieving pain. The company develops synthesized and characterized new non-opioid and non-liver toxic molecules that activate pain signaling pathways in the midbrain's periaqueductal grey (PAG) region, enabling patients to overcome risks associated with current pain medicines, including lack of abuse as a non-opioid and no liver toxicity.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 7 highland Avenue
  • San Rafael, CA 94901
  • United States
+1 (504)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 7 highland Avenue
  • San Rafael, CA 94901
  • United States
+1 (504)

South Rampart Pharma Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

South Rampart Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series A) 22-Jan-2025 $3.2M Completed Clinical Trials - Phase 2
6. Grant Completed Clinical Trials - Phase 1
5. Grant 15-Sep-2023 Completed Clinical Trials - Phase 1
4. Grant 01-May-2023 Completed Clinical Trials - Phase 1
3. Corporate 01-Oct-2022 Completed Clinical Trials - Phase 2
2. Grant 01-Sep-2021 $1.9M $4M Completed Clinical Trials - Phase 1
1. Corporate 01-Sep-2020 $4M $4M Completed Clinical Trials - Phase 1
To view South Rampart Pharma’s complete valuation and funding history, request access »

South Rampart Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed
To view South Rampart Pharma’s complete cap table history, request access »

South Rampart Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a clinical-stage biotech company designed to address the need for a safe and effective approach to relievin
Drug Discovery
San Rafael, CA
4 As of 2026

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

South Rampart Pharma Competitors (1)

One of South Rampart Pharma’s competitors is Centrexion Therapeutics, a Venture Capital-Backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Centrexion Therapeutics Venture Capital-Backed Boston, MA
You’re viewing 1 of 1 competitors. Get the full list »

South Rampart Pharma Patents

South Rampart Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250339391-A1 Methods for effective management of pain Pending 18-Apr-2024
AU-2024234362-A1 Nanoparticle formulations for a non-opioid drug Pending 10-Mar-2023
EP-4676444-A1 Nanoparticle formulations for a non-opioid drug Pending 10-Mar-2023
WO-2024191741-A1 Nanoparticle formulations for a non-opioid drug Inactive 10-Mar-2023
US-11458142-B2 Compositions and methods for ameliorating pain Active 25-Aug-2017 A61K31/5375
To view South Rampart Pharma’s complete patent history, request access »

South Rampart Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

South Rampart Pharma Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Gulf South Angels Angel Group Minority
Ochsner Ventures Corporate Venture Capital Minority
Small Business Innovation Research and Small Business Technology Transfer Programs Government Minority
Ochsner Health Corporation Minority
National Institutes of Neurological Disorders and Stroke Government
You’re viewing 5 of 6 investors. Get the full list »

South Rampart Pharma FAQs

  • When was South Rampart Pharma founded?

    South Rampart Pharma was founded in 2016.

  • Where is South Rampart Pharma headquartered?

    South Rampart Pharma is headquartered in San Rafael, CA.

  • What is the size of South Rampart Pharma?

    South Rampart Pharma has 4 total employees.

  • What industry is South Rampart Pharma in?

    South Rampart Pharma’s primary industry is Drug Discovery.

  • Is South Rampart Pharma a private or public company?

    South Rampart Pharma is a Private company.

  • What is the current valuation of South Rampart Pharma?

    The current valuation of South Rampart Pharma is .

  • What is South Rampart Pharma’s current revenue?

    The current revenue for South Rampart Pharma is .

  • How much funding has South Rampart Pharma raised over time?

    South Rampart Pharma has raised $9.1M.

  • Who are South Rampart Pharma’s investors?

    Gulf South Angels, Ochsner Ventures, Small Business Innovation Research and Small Business Technology Transfer Programs, Ochsner Health, and National Institutes of Neurological Disorders and Stroke are 5 of 6 investors who have invested in South Rampart Pharma.

  • Who are South Rampart Pharma’s competitors?

    Centrexion Therapeutics is a competitor of South Rampart Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process